Intelligence / Healthtech / Health Funding Register / Medicenna Therapeutics Corp.
Fundingraised $253K6 Jul 2026
Medicenna Therapeutics Corp.
6 Jul 2026: Raised $253K · Toronto, A6. Recorded in the SEC Form D data sets.
- Filed
- 6 Jul 2026
- Location
- Toronto, A6
- State
- Ontario, Canada
- Industry
- Biotechnology
- Amount raised
- $253K
- Offering size
- $2.3M
- Revenue range
- Decline to Disclose
- Entity type
- Corporation
- Jurisdiction
- Canada (Federal Level)
- First sale
- 2026-05-28
- Securities
- Equity, Options, Each Unit is comprised of 1 common share and 1/2 of 1 common share purchase warrant. Each Warrant entitles the holder thereof to purchase one additional Share at an exercise price of CDN$0.65 per Share for a period of 3 years following May 28, 2026.
- Investors so far
- 3
- SEC CIK
- 0001807983
What this signal means
Companies buy in the months after they raise: new hires, new vendors, new markets.
- 137 added in the 30 days to 30 Sept 2026.
- 114 of them (29%) raised $5M or more.
Reach them with AOS
Find the decision makers at Medicenna Therapeutics Corp.
AOS maps the buying committee, finds verified work emails and drafts outreach that cites this funding signal, for your approval.
More from Ontario, Canada
Health Funding Register
Source: SEC Form D data sets, data to 30 Sept 2026. New Form D notices filed in Q3 2026 by health and life-sciences companies; pooled investment funds and amendments excluded. Amounts are as reported to the SEC. AOS shows what the public record says; it does not verify or endorse the company.